Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRHI Magnesita Regulatory News (RHIM)

Share Price Information for RHI Magnesita (RHIM)

Share Price is delayed by 15 minutes
Get Live Data
2,770.00    40.00 (1.47%)
Bid:
2,760.00
Ask:
2,785.00
Spread: 25.00 (0.906%)
Market Cap: £1.31b
RHIM Live PriceLast checked at - London Stock Exchange

Intraday RHI Magnesita Share Chart

Debt Financing Update

2 Dec 2021 07:00

RNS Number : 2909U
RHI Magnesita N.V.
02 December 2021
 

RHI Magnesita N.V.

("RHI Magnesita" or the "Company" or "Group")

DEBT FINANCING UPDATE

RHI Magnesita today announces that it has agreed €400 million of new debt financing comprising a new €250 million ESG-linked Schuldschein and a new €150 million ESG-linked Bilateral Facility. The new financing has been obtained at attractive rates of interest, reflecting high demand from lenders and Schuldschein investors and will provide the Group with additional liquidity and financial flexibility.

€250 million Schuldschein and €150 million Bilateral Facility

RHI Magnesita has issued a new Schuldschein for a total principal amount of 250 million and maturities ranging from 5.5 years to 10 years. The weighted average coupon of the Schuldschein on issuance is 0.80% per annum, with 134 million of the principal loan amount attracting a fixed rate of interest and the remaining 116 million a floating rate of interest, as set out in the Appendix below.

Demand for participation in the transaction was strong and the final size was increased to accommodate additional appetite from investors. The lead arrangers of the Schuldschein were Landesbank Hessen Thüringen Girozentrale ("Helaba") and Raiffeisen Bank International AG ("RBI").

A new 150 million ESG-linked Bilateral Facility with ING has also been agreed, with final maturity in May 2025.

The margin payable on both the Schuldschein and Bilateral Facility will be adjusted based on the Group's EcoVadis ESG rating performance. RHI Magnesita is currently rated 'Gold' by EcoVadis and will seek to further improve its ESG performance and ratings through the execution of its sustainability strategy.

Extension of €600 million Syndicated RCF

The Group has exercised the second of three extension options on its €600 million ESG-linked Syndicated RCF, with final maturity now in January 2027. All other terms of the Syndicated RCF remain as agreed in July 2021.

Ian Botha, Chief Financial Officer, said:

"The agreement of €400 million of new financing alongside the extension of our €600 million Syndicated RCF demonstrates strong support from our banking group and credit investors. Raising new facilities and extending our debt maturity profile provides RHI Magnesita with additional financial flexibility and liquidity as we execute our strategic initiatives and pursue acquisition opportunities, in line with our objective to grow in new markets. The facilities are all ESG-linked, consistent with our commitment to sustainability."

 

For further enquiries, please contact:

Chris Bucknall, Head of Investor Relations

+43 699 1870 6490

chris.bucknall@rhimagnesita.com

 

About RHI Magnesita

RHI Magnesita is the leading global supplier of high‐grade refractory products, systems and solutions which are critical for high‐temperature processes exceeding 1,200°C in a wide range of industries, including steel, cement, non‐ferrous metals and glass. With a vertically integrated value chain, from raw materials to refractory products and full performance‐based solutions, RHI Magnesita serves customers around the world, with around 12,000 employees in 28 main production sites and more than 70 sales offices. RHI Magnesita intends to build on its leadership in revenue, scale, product portfolio and diversified geographic presence to expand further in high growth markets.

The Group maintains a premium listing on the Official list of the London Stock Exchange (symbol: RHIM) and is a constituent of the FTSE 250 index, with a secondary listing on the Vienna Stock Exchange (Wiener Börse). For more information please visit: www.rhimagnesita.com

 

Definitions

"6M€"

6 month Euribor

"Bilateral Facility" or "ESG-linked Bilateral Facility"

150 million debt facility agreement with ING dated 30 November 2021

"bps"

basis points

"ESG"

Environmental, social and governance

"ING"

ING-DiBa AG

"Schuldschein" or "ESG-linked Schuldschein"

250 million Schuldscheindarlehen bonded loan agreement dated 30 November 2021

"Syndicated RCF"

600 million syndicated revolving credit facility dated 26 July 2021

 

 

 

APPENDIX

The coupons payable and maturity dates for the new ESG-linked 250 million Schuldschein are as follows:

Tenor

Coupon1,2

million

5.5 years

75 bps

54.5

5.5 years

6M€ + 75 bps

97.5

7 years

85 bps

74.5

7 years

6M€ + 85 bps

12.0

8 years

6M€ + 90 bps

5.0

10 years

127.7 bps

5.0

10 years

6M€ + 110 bps

1.5

250.0

Notes:

1. Margin step up: at a Net Debt to EBITDA ratio of 3.5x or above, an additional margin of 50 bps is payable.

2. 6 month Euribor on 30 November 2021 was -0.538%. If 6 month Euribor is negative, floating coupons are calculated using a base rate of zero. The Group intends to enter into interest rate swaps to reduce its exposure to future interest rate volatility.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IODEAXAFESKFFFA
Date   Source Headline
1st Jun 20268:49 amRNSTotal Voting Rights
13th May 20264:07 pmRNSResult of AGM
1st May 20268:57 amRNSTotal Voting Rights
29th Apr 20267:00 amRNSQ1 Trading Update
1st Apr 20269:11 amRNSTotal Voting Rights
26th Mar 20262:54 pmRNSNotice of AGM
10th Mar 202611:18 amRNSDirector/PDMR Shareholding
2nd Mar 20267:55 amRNSAnnual Financial Report
2nd Mar 20267:49 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNS2025 Full Year Results
13th Feb 20268:56 amRNSNotice of Results
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
10th Dec 20259:10 amRNSDirectorate change
10th Nov 20257:00 amRNSTrading Update
7th Nov 202511:48 amRNSDirectorate change
3rd Nov 202511:54 amRNSDirectorate change
1st Oct 20257:00 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSTotal Voting Rights
30th Jul 20257:00 amRNS2025 Half Year Results
16th Jul 20257:00 amRNSNotice of Results
30th Jun 20258:29 amRNSDirector Declaration
2nd Jun 20258:53 amRNSTotal Voting Rights
29th May 20259:26 amRNSDirector/PDMR Shareholding
23rd May 20258:12 amRNSDirector Declaration
7th May 20254:11 pmRNSResult of AGM
7th May 20257:00 amRNSQ1 2025 Trading Update
1st May 20259:07 amRNSTotal Voting Rights
7th Apr 20253:36 pmRNSDirector/PDMR Shareholding
3rd Apr 20254:17 pmRNSDirector/PDMR Shareholding
1st Apr 20254:49 pmRNSDirector/PDMR Shareholding
1st Apr 20259:13 amRNSTotal Voting Rights
28th Mar 20254:12 pmRNSDirector/PDMR Shareholding
27th Mar 20253:30 pmRNSNotice of AGM
27th Mar 20252:50 pmRNSDirectorate Change
24th Mar 202512:32 pmRNSNotice of AGM
7th Mar 202510:13 amRNS2025 Long Term Incentive Plan Awards
27th Feb 20257:00 amRNS2024 Full Year Results
17th Feb 20257:00 amRNSNotice of Results
3rd Feb 20259:11 amRNSTotal Voting Rights
28th Jan 20251:59 pmRNSCompletion of Resco transaction
2nd Jan 20257:00 amRNSTotal Voting Rights
28th Nov 202410:09 amRNSDirector/PDMR Shareholding
21st Nov 20249:03 amRNSDirector/PDMR Shareholding
11th Nov 20247:00 amRNSQ3 2024 Trading Update
7th Oct 202410:10 amRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSTotal Voting Rights
27th Sep 202411:15 amRNSExercise of LTIP options by PDMR
19th Aug 202410:31 amRNSDirector/PDMR Shareholding
12th Aug 20242:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.